Antiarrhythmic activity of some isoquinoline derivatives determined by a rapid screening procedure in the mouse.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology / Q000633:toxicity; D002725:Chloroform; D004155:Diphenhydramine / Q000494:pharmacology; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D008722:Methods; D008729:Methoxamine / Q000494:pharmacology; D051379:Mice; D009278:Naphazoline / Q000494:pharmacology; D010115:Oxyphenonium / Q000494:pharmacology / Q000633:toxicity; D010208:Papaverine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology / Q000633:toxicity; D011433:Propranolol / Q000494:pharmacology / Q000633:toxicity; D011802:Quinidine / Q000494:pharmacology / Q000633:toxicity; D011804:Quinolines / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology; D014693:Ventricular Fibrillation / Q000139:chemically induced
D000889:Anti-Arrhythmia Agents; D011804:Quinolines; D010656:Phenylephrine; D001285:Atropine; D002725:Chloroform; D012110:Reserpine; D004155:Diphenhydramine; D011433:Propranolol; D010115:Oxyphenonium; D010208:Papaverine; D009278:Naphazoline; D008729:Methoxamine; D011802:Quinidine; D011342:Procainamide